Amy Goldstein, MD

I am a child neurologist with a subspecialty focus and expertise in primary mitochondrial disorders. I have been the Clinical Director of the Mitochondrial Medicine Frontier Program since July 2017. Under my leadership, we have expanded the clinical service to include inpatient consultations at CHOP as well as the Hospital of the University of Pennsylvania (for adults), and we have quadrupled the outpatient patient volume. I am actively involved in direct patient care, clinical diagnosis, and management, striving to make ongoing improvements in patient care. We perform retrospective and prospective natural history studies and interventional clinical trials where I serve as Physician Lead.

In addition to my clinical service, my major contributions to the field of Mitochondrial Medicine include education and awareness. I serve the patients and families by volunteering my service for the major patients’ advocacy support groups. I am a past member of the Scientific and Medical Advisory Board for the United Mitochondrial Disease Foundation (UMDF) and have served as a medical advisor for MitoAction. I have served the clinicians who care for patients with mitochondrial disease as a board member and immediate past president of the Mitochondrial Medicine Society, and I am a founding member of the Mitochondrial Care Network. I am a contributing author to numerous publications and am frequently invited to give talks at national and international meetings. I am also a faculty member of CMEM (Center for Mitochondrial Epigenomic Medicine) and Professor of Clinical Pediatrics at the University of Pennsylvania, where I also hold a secondary appointment in Neurology.